INVITRO EVALUATION OF BRL 42715, A NOVEL BETA-LACTAMASE INHIBITOR

[1] COMPARATIVE ACTIVITIES OF THE BETA-LACTAMASE INHIBITORS YTR-830, SODIUM CLAVULANATE, AND SULBACTAM COMBINED WITH AMOXICILLIN OR AMPICILLIN [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (04) : 580 - 582

[2] BETA-LACTAM RESISTANCE IN CLINICAL ISOLATES OF ESCHERICHIA-COLI CAUSED BY ELEVATED PRODUCTION OF THE AMPC-MEDIATED CHROMOSOMAL BETA-LACTAMASE [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (04) : 427 - 433

[3] CHARACTERIZATION OF BETA-LACTAMASES [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (03) : 259 - 263

[4] EMERGENCE OF RESISTANCE IN GRAM-NEGATIVE BACTERIA DURING THERAPY WITH EXPANDED-SPECTRUM CEPHALOSPORINS [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1987, 6 (04) : 456 - 459

[5] CP-45,899, A BETA-LACTAMASE INHIBITOR THAT EXTENDS ANTIBACTERIAL SPECTRUM OF BETA-LACTAMS - INITIAL BACTERIOLOGICAL CHARACTERIZATION [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 14 (03) : 414 - 419

[6] INCONSISTENCY OF SYNERGY BETWEEN THE BETA-LACTAMASE INHIBITOR CP-45,899 AND BETA-LACTAM ANTIBIOTICS AGAINST MULTIPLY DRUG-RESISTANT ENTEROBACTERIACEAE AND PSEUDOMONAS SPECIES [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (02) : 361 - 363

[7] DEVELOPMENT OF RESISTANCE TO CEPHALOSPORINS IN CLINICAL STRAINS OF CITROBACTER SPP [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (05) : 591 - 595

[8] INVITRO SYNERGISTIC PROPERTIES OF CLAVULANIC ACID, WITH AMPICILLIN, AMOXYCILLIN AND TICARCILLIN [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1980, 6 (04) : 455 - 470

[9] HUNTER PA, 1980, CURRENT CHEEMOTHERAP, V1, P340

[10] COMPARATIVE ACTIVITIES OF THE BETA-LACTAMASE INHIBITORS YTR 830, CLAVULANATE, AND SULBACTAM COMBINED WITH AMPICILLIN AND BROAD-SPECTRUM PENICILLINS AGAINST DEFINED BETA-LACTAMASE-PRODUCING AEROBIC GRAM-NEGATIVE BACILLI [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (06) : 980 - 985

[1] COMPARATIVE ACTIVITIES OF THE BETA-LACTAMASE INHIBITORS YTR-830, SODIUM CLAVULANATE, AND SULBACTAM COMBINED WITH AMOXICILLIN OR AMPICILLIN [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (04) : 580 - 582

[2] BETA-LACTAM RESISTANCE IN CLINICAL ISOLATES OF ESCHERICHIA-COLI CAUSED BY ELEVATED PRODUCTION OF THE AMPC-MEDIATED CHROMOSOMAL BETA-LACTAMASE [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (04) : 427 - 433

[3] CHARACTERIZATION OF BETA-LACTAMASES [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (03) : 259 - 263

[4] EMERGENCE OF RESISTANCE IN GRAM-NEGATIVE BACTERIA DURING THERAPY WITH EXPANDED-SPECTRUM CEPHALOSPORINS [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1987, 6 (04) : 456 - 459

[5] CP-45,899, A BETA-LACTAMASE INHIBITOR THAT EXTENDS ANTIBACTERIAL SPECTRUM OF BETA-LACTAMS - INITIAL BACTERIOLOGICAL CHARACTERIZATION [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 14 (03) : 414 - 419

[6] INCONSISTENCY OF SYNERGY BETWEEN THE BETA-LACTAMASE INHIBITOR CP-45,899 AND BETA-LACTAM ANTIBIOTICS AGAINST MULTIPLY DRUG-RESISTANT ENTEROBACTERIACEAE AND PSEUDOMONAS SPECIES [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (02) : 361 - 363

[7] DEVELOPMENT OF RESISTANCE TO CEPHALOSPORINS IN CLINICAL STRAINS OF CITROBACTER SPP [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (05) : 591 - 595

[8] INVITRO SYNERGISTIC PROPERTIES OF CLAVULANIC ACID, WITH AMPICILLIN, AMOXYCILLIN AND TICARCILLIN [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1980, 6 (04) : 455 - 470

[9] HUNTER PA, 1980, CURRENT CHEEMOTHERAP, V1, P340

[10] COMPARATIVE ACTIVITIES OF THE BETA-LACTAMASE INHIBITORS YTR 830, CLAVULANATE, AND SULBACTAM COMBINED WITH AMPICILLIN AND BROAD-SPECTRUM PENICILLINS AGAINST DEFINED BETA-LACTAMASE-PRODUCING AEROBIC GRAM-NEGATIVE BACILLI [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (06) : 980 - 985